EDP Sciences logo
Search
Menu
All issues Volume 45 / No 5 (September-October 2005) Reprod. Nutr. Dev., 45 5 (2005) 559-579 References
Free Access
Issue
Reprod. Nutr. Dev.
Volume 45, Number 5, September-October 2005
Page(s) 559 - 579
DOI https://doi.org/10.1051/rnd:2005046
References of Reprod. Nutr. Dev. 45 559-579
  1. Stillwell W, Wassall SR. Docosahexaenoic acid: Membrane properties of a unique fatty acid. Chem Phys Lipids 2003, 126: 1-27 [CrossRef] [PubMed].
  2. Carroll KK. Dietary fats and cancer. Am J Clin Nutr 1991, 53: 1064S-1067S [PubMed].
  3. Zerouga M, Stillwell W, Stone J, Powner A, Dumaual AC, Jenski LJ. Phospholipid class as a determinant in docosahexaenoic acid's effect on tumor cell viability. Anticancer Res 1996, 16: 2863-2868 [PubMed].
  4. McLennan P, Howe P, Abeywardena M, Muggli R, Raederstorff D, Mano M, Rayner T, Head R. The cardiovascular protective role of docosahexaenoic acid. Eur J Pharmacol 1996, 300: 83-89 [CrossRef] [PubMed].
  5. Kremer JM, Lawrence DA, Jubiz W, DiGiacomo R, Rynes R, Bartholomew LE, Sherman M. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum 1990, 33: 810-820 [PubMed].
  6. Yokoyama A, Hamazaki T, Ohshita A, Kohno N, Sakai K, Zhao GD, Katayama H, Hiwada K. Effect of aerosolized docosahexaenoic acid in a mouse model of atopic asthma. Int Arch Allergy Immunol 2000, 123: 327-332 [CrossRef] [PubMed].
  7. Das UN. Beneficial effect of eicosapentaenoic and docosahexaenoic acids in the management of systemic lupus erythematosus and its relationship to the cytokine network. Prostaglandins Leuktot Essent Fat Acids 1994, 51: 207-213.
  8. Pawlosky RJ, Salem N Jr. Ethanol exposure causes a decrease in docosahexaenoic acid and an increase in docosapentaenoic acid in feline brains and retinas. Am J Clin Nutr 1995, 61: 1284-1289 [PubMed].
  9. Birch EE, Birch DG, Hoffman DR, Uauy R. Dietary essential fatty acid supply and visual acuity development. Invest Ophthamol Vis Sci 1992, 33: 3242-3253.
  10. De Caterina R, Caprioli R, Giannessi D, Sicari R, Galli C, Lazzerini G, Bernini W, Carr L, Rindi P. n-3 fatty acids reduce proteinuria in patients with chronic glomerular disease. Kidney Int 1993, 44: 843-850 [PubMed].
  11. Knapp HR. Omega-3 fatty acids in respiratory diseases: a review. J Am Coll Nutr 1995, 14: 18-23 [PubMed].
  12. Martinez M, Vazquez E, Garcia-Silva MT, Manzanares J, Bertram JM, Castello F, Mougan I. Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders. Am J Clin Nutr 2000, 71: 376S-385S [PubMed].
  13. Tomobe YI, Morizawa K, Tsuchida M, Hibino H, Nakano Y, TanakaY. Dietary docosahexaenoic acid suppresses inflammation and immunoresponses in contact hypersensitivity reaction in mice. Lipids 2000, 35: 61-69 [PubMed].
  14. Grimminger F, Mayser P, Papavassilis C, Thomas M, Schlotzer E, Heuer KU, Fuhrer D, Hinsch KD, Walmrath D, Schill WB. A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profile. Clin Invest 1993, 71: 634-643.
  15. Freedman SD, Katz MH, Parker EM, Laposata M, Urman MY, Alvarez JG. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice. Proc Natl Acad Sci USA 1999, 96: 13995-14000 [CrossRef] [PubMed].
  16. Esteve-Comas M, Nunez MC, Fernandez-Banares F, Abad-Lacruz A, Gik A, Cabre E, Gonzales-Huix F, Bertran X, Gassull MA. Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease. Gut 1993, 34B: 1371-1373.
  17. Laugharne JD, Mellor JE, Peet M. Fatty acids and schizophrenia. Lipids 1996, 31 Suppl: S163-S165.
  18. Hibbeln JR, Salem N Jr. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 1995, 62: 1-9 [PubMed].
  19. Lim SY, Suzuki H. Intakes of dietary docosahexaenoic acid ethyl ester and egg phosphatidylcholine improve maize learning ability in young and old mice. J Nutr 2000, 139: 1629-1632.
  20. Menkes JH, Alter M, Steigleder GK, Weakley DR, Sung JH. A sex-linked recessive disorder with retardation of growth, peculiar hair and focal cerebral and cerebellar degeneration. Pediatrics 1962, 29: 764-779 [PubMed].
  21. Fevang P, Saav H, Hostmark AT. Dietary fish oils and long-term malaria protection in mice. Lipids 1995, 30: 437-441 [PubMed].
  22. Bernsohn J, Stephanides LM. Aetiology of multiple sclerosis. Nature 1967, 215: 821-823 [PubMed].
  23. Wagner W, Nootbaar-Wagner U. Prophylactic treatment of migraine with gamma-linolenic and alpha linolenic acids. Cephalalgia 1997, 17: 127-130 [CrossRef] [PubMed].
  24. Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc 2002, 61: 345-358 [CrossRef] [PubMed].
  25. Kubo K, Sekine S, Saito M. Docosahexaenoic acid-containing phosphatidylethanolamine in the external layer of liposomes protects docosahexaenoic acid from 2,2'-azobis (2-aminopropane)dihydrochloride-mediated lipid peroxidation. Arch Biochem Biophys 2003, 410: 141-148 [CrossRef] [PubMed].
  26. Mitchell DC, Litman BJ. Modulation of receptor signaling by phospholipid acyl chain composition. In: Mostofsky D, Yehuda S, Salem N Jr (Eds), Fatty Acids: Physiological and Behavioral Functions, Humana Press Inc, Totowa, NJ, 2001, p 23-40.
  27. Jump DB. Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol 2002, 13: 155-164 [CrossRef] [PubMed].
  28. Stillwell W. Docosahexaenoic acid and membrane lipid domains. Curr Organic Chem 2000, 4: 1169-1183.
  29. Salem NJ, Kim HY, Yergey J A. Docosahexaenoic acid: membrane function and metabolism. In: Simopolous AP, Kifer RR, Martin RE (Eds), Health Effects of Polyunsaturated Fatty Acids in Seafoods, Academic Press, New York, 1986, p 319-351.
  30. Breckenridge WC, Gombos G, Morgan IG. The lipid composition of adult rat brain synaptosomal membranes. Biochim Biophys Acta 1972, 266: 695-707 [CrossRef] [PubMed].
  31. Neill AR, Masters CJ. Metabolism of fatty acids by bovine spermatozoa. J Reprod Fertil 1973, 34: 279-287 [PubMed].
  32. Poulos A, Darin-Bennet A, White IG. The phospholipids-bound fatty acids and aldehydes of mammalian spermatopzoa. Comp Biochem Physiol 1973, 46: 541-549 [CrossRef].
  33. Wiegand RD, Anderson R E. Phospholipid molecular species of frog rod outer segment membranes. Exp Eye Res 1983, 37: 159-173 [CrossRef] [PubMed].
  34. Anderson RE, Maude MB, Feldman GL. Lipids of ocular tissues. The phospholipids of mature bovine iris. Exp Eye Res 1970, 9: 281-284 [PubMed].
  35. Miljanich GP, Sklar LA, White DL, Dratz EA. Disaturated and dipolyunsaturated phospholipids in the bovine retinal rod outer segment disk membrane. Biochim Biophys Acta 1979, 552: 294-306 [PubMed].
  36. Bell MV, Dick JR, Buda C. Molecular speciation of fish sperm phospholipids: large amounts of dipolyunsaturated phosphatidylserine. Lipids 1997, 32: 1085-1091 [PubMed].
  37. Van Meter AR, Ehringer WD, Stillwell W, Blumenthal E, Jenski LJ. Aged lymphocyte proliferation following incorporation and retention of dietary omega-3 fatty acids. Mechan Ageing Dev 1994, 75: 95-114.
  38. Robinson DR, Xu LL, Knoell CT, Tateno S, Olesiak W. Modification of spleen phospholipid fatty acid composition by dietary fish oil and by n-3 fatty acid ethyl esters. J Lipid Res 1993, 34: 1423-1434 [PubMed].
  39. Anderson RE, Sperling L. Lipids of ocular tissues. VII. Positional distribution of the fatty acids in the phospholipids of bovine retina rod outer segments. Arch Biochem Biophys 1971, 144: 673-677 [CrossRef] [PubMed].
  40. Stubbs CD, Smith AD. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta 1984, 779: 89-137 [PubMed].
  41. Emmelot P, van Hoeven RP. Phospholipid unsaturation and plasma membrane organization. Chem Phys Lipids 1975, 14: 236-246 [CrossRef] [PubMed].
  42. Salem N Jr, Bougnoux P. Asymmetry of phosphatidylethanolamine molecular species in the human lymphocyte plasma membrane. 24th Intl Conf Biochem Lipids 1983, p 44.
  43. Knapp HR, Hullin F, Salem N Jr. Asymmetric incorporation of dietary n-3 fatty acids into membrane aminophospholipids of human erythrocytes. J Lipid Res 1994, 35: 1283-1291 [PubMed].
  44. Dratz EA, Van Breeman JF, Kamps KM, Keegstra W, Van Bruggen EF. Two-dimensional crystallization of bovine rhodopsin. Biochim Biophys Acta 1985, 832: 337-342 [PubMed].
  45. Holte LL, Peter SA, Sinnwell TM, Gawrisch K. 2H nuclear magnetic resonance order profiles suggest a change of molecular shape for phospahtidylcholines containing a polyunsaturated acyl chain. Biophys J 1995, 68: 2396-2403 [PubMed].
  46. Eldho NV, Feller SE, Tristram-Nagle S, Polozov IV, Gawrisch K. Polyunsaturated docosahexaenoic vs. docosapentaenoic acid - differences in lipid matrix properties from the loss of one double bond. J Am Chem Soc 2003, 125: 6409-6421 [CrossRef] [PubMed].
  47. Saiz L, Klein ML. Structural properties of a highly polyunsaturated lipid bilayer from molecular dynamics simulations. Biophys J 2001, 81: 204-216 [PubMed].
  48. Feller SE, Gawrisch K, Woolf TB. Rhodopsin exhibits a preference for solvation by polyunsaturated docosahexaenoic acid. J Amer Chem Soc 2002, 125: 4434-4435.
  49. Huber T, Rajamoorthi K, Kurze VF, Beyer K, Brown MF. Structure of docosahexaenoic acid-containing phospholipid bialyers as studied by 2H NMR and molecular dynamics simulations. J Amer Chem Soc 2002, 124: 298-309 [CrossRef].
  50. Straume M, Litman BJ. Equilibrium and dynamic structure of large, unilamellar, unsaturated acyl chain phosphatidylcholine vesicles. Higher order analysis of 1,6-diphenyl-1,3,5-hexatriene and 1-[4-(trimethylammonio)phenyl]-6-phenyl-1,3,5-hexatriene anisotropy decay. Biochemistry 1987, 26: 5113-5120 [CrossRef] [PubMed].
  51. Stubbs CD. The structure and function of docosahexaenoic acid in membranes. In: Sinclair A, Gibson R (Eds), Essential Fatty Acids and Eicosanoids, AOCS, Champaign, Illinois, 1992, p 116-121.
  52. Salem N Jr, Niebylski CD. The nervous system has an absolute molecular species requirement for proper function. Mol Membrane Biol 1995, 12: 131-134.
  53. Mitchell DC, Litman BJ. Molecular order and dynamics in bilayers consisting of highly polyunsaturated phospholipids. Biophys J 1998, 74: 879-891 [PubMed].
  54. Kamada T, Yamashita T, Baba Y, Kai M, Setoyama S, Chuman Y, Otsuji S. Dietary sardine oil increases erythrocyte membrane fluidity in diabetic patients. Diabetes 1986, 35: 604-611 [PubMed].
  55. Ernst E. Effects of n-3 fatty acids on blood rheology. J Int Med 1994, 225: 129-132.
  56. Brown ER, Subbaiah PV. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on human skin fibroblasts. Lipids 1994, 29: 825-829 [PubMed].
  57. Calder PC, Yaqoob P, Harvey DJ, Watts A, Newsholme E.A. Incorporation of fatty acids by concanavalin A-stimulated lymphocytes and the effect on fatty acid composition and membrane fluidity. Biochem J 1994, 300: 509-518 [PubMed].
  58. Sobajima T, Tamiya-Koizumi K, Ishihara H, Kojima K. Effects of fatty acid modification of ascites tumor cells on pulmonary metastasis in rat. Jpn J Cancer Res 1986, 77: 657-663 [PubMed].
  59. Yorek M, Leeney E, Dunlap J, Ginsberg B. Effect of fatty acid composition on insulin and IGF-I binding in retinoblastoma cells. Invest Ophthalmol Vis Sci 1989, 30: 2087-2092 [PubMed].
  60. Clamp AG, Ladha S, Clark DC, Grimble RF, Lund EK. The influence of dietary lipids on the composition and membrane fluidity of rat hepatocyte plasma membranes. Lipids 1997, 32: 179-184 [PubMed].
  61. Wahnon R, Cogan U, Mokady S. Dietary fish oil modulates the alkaline phosphatase activity and not the fluidity of rat intestinal microvillus membrane. J Nutr 1992, 122: 1077-1084 [PubMed].
  62. Popp-Snijders C, Schouten JA, Van Blitterswijk WJ, Van Der Veen EA. Changes in membrane lipid composition of human erythrocytes after dietary supplementation of (n-3) polyunsaturated aftty acids. Maintenance of membrane fluidity. Biochim Biophys Acta 1986, 854: 31-37.
  63. Gibney MJ, Bolton-Smith C. The effect of a dietary supplement of n-3 polyunsaturated fat on platelet lipid composition, platelet function and platelet plasma membrane fluidity in healthy volunteers. Br J Nutr 1988, 60: 5-12 [CrossRef] [PubMed].
  64. Treen M, Uauy RD, Jameson DM, Thomas VL, Hoffman DR. Effect of docosahexaenoic acid on membrane fluidity and function in intact cultured Y-79 retinoblastoma cells. Arch Biochem Biophys 1992, 294: 564-570 [CrossRef] [PubMed].
  65. Stillwell W, Jenski LJ, Crump FT, Ehringer W. Effect of docosahexaenoic acid on mouse mitochondrial membrane properties. Lipids 1997, 32: 497-506 [PubMed].
  66. Niebylski CD, Salem N Jr. A calorimetric investigation of a series of mixed-chain polyunsaturated phopsphatidylcholines: effects of sn-2 chain length and degree of unsaturation. Biophys J 1994, 67: 2387-2393 [PubMed].
  67. Dratz EA, Deese AJ. The role of docosahexaenoic acid in biological membranes: Examples from photoreceptors and model membrane bilayers. In: Simopolous AP, Kifer RR, Martin RE (Eds), Health Effects of Polyunsaturated Fatty Acids in Seafoods, Academic Press, New York, 1986, p 319-351.
  68. Smaby JM, Momsen MM, Brockman HL, Brown RE. Phosphatidylcholine acyl unsaturation modulates the decrease in interfacial elasticity induced by cholesterol. Biophys J 1997, 73: 1492-1505 [PubMed].
  69. Koenig BW, Strey HH, Gawrisch K. Membrane lateral compressibility determined by NMR and x-ray diffraction: effect of acyl chain polyunsaturation. Biophys J 1997, 73: 1954-1966 [PubMed].
  70. Epand RM. Lipid polymorphism and protein-lipid interactions. Biochim Biophys Acta 1998, 1367: 353-368.
  71. Gruner SM. Intrinsic curvature hypothesis for biomembrane lipid composition: a role for nonbilayer lipids. Proc Natl Acad Sci USA 1985, 82: 3665-3669 [PubMed].
  72. Killian JA. Hydrophobic mismatch between proteins and lipids in membranes. Biochim Biophys Acta 1998, 1376: 401-415 [PubMed].
  73. Litman BJ, Mitchell DC. A role for phospholipid polyunsaturation in modulating membrane protein function. Lipids 1996, 31: S193-S197 [PubMed].
  74. Mitchell DC, Straume M, Litman BJ. Role of sn-1-saturated, sn-2-polyunsaturated phospholipids in control of membrane receptor conformational equilibrium: effects of cholesterol and acyl chain unsaturation on the metarhodopsin I/metarhodopsin II equilibrium. Biochemistry 1992, 31: 662-670 [CrossRef] [PubMed].
  75. Brown MF. Modulation of rhodopsin function by properties of the membrane bilayer. Chem Phys Lipids 1994, 73: 159-180 [CrossRef] [PubMed].
  76. Mitchell DC, Litman BJ. Phospholipid acyl chain unsaturation determins cholesterol effects on rhodopsin photoactivation. Biophys J 1997, 72: A310.
  77. Hendriks T, Klompmakers AA, Daemen FJM, Bonting SL. Biochemical aspects of the visual process. XXXII. Movement of sodium ions through bilayers composed of retinal and rod outer segment lipids. Biochim Biophys Acta 1976, 433, 271-281.
  78. Demel RA, Geurts van Kessel WSM, Van Deenan LLM. The properties of polyunsaturated lecithins in monolayers and liposomes and the interactions of these lecithins with cholesterol. Biochim Biophys Acta 1972, 266: 26-40 [PubMed].
  79. Stillwell W, Ehringer WD, Jenski LJ. Docosahexaenoic acid increases permeability of lipid vesicles and tumor cells. Lipids 1993, 28: 103-108 [PubMed].
  80. Huster D, Arnold K, Gawrisch K. Influence of docosahexaenoic acid and cholesterol on lateral lipid organization in phospholipid mixtures. Biochemistry 1998, 37: 17299-17308 [CrossRef] [PubMed].
  81. Brand MD, Couture P, Hulbert AJ. Liposomes from mammalian liver mitochondria are more polyunsaturated and leakier to protons than those from reptiles. Comp Biochem Physiol 1994, 108B: 181-188.
  82. Newmeyer DD, Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 2003, 112: 481-490 [CrossRef] [PubMed].
  83. Ahkong QF, Fisher D, Tampion W, Lucy JA. The fusion of erythrocytes by fatty acids, esters, retinol and alpha-tocopherol. Biochem J 1973, 136: 147-155 [PubMed].
  84. Meers P, Hong K, Papahadjopoulos D. Free fatty acid enhancement of cation-induced fusion of liposomes: synergism with synexin and other promoters of vesicle aggregation. Biochemistry 1988, 27: 6784-6794 [CrossRef] [PubMed].
  85. Ehringer W, Belcher D, Wassall SR, Stillwell W. A comparison of the effects of linolenic (18:3$\Omega$3) and docosahexaenoic (22:6$\Omega$3) acids on phospholipid bilayers. Chem Phys Lipids 1990, 54: 79-88 [CrossRef] [PubMed].
  86. Pascale AW, Ehringer WD, Stillwell W, Sturdevant LK, Jenski LJ. Omega-3 fatty acid modification of membrane structure and function. II. Alteration by docosahexaenoic acid of tumor cell sensitivity to immune cytolysis. Nutr Cancer 1993, 19: 147-157 [PubMed].
  87. Jenski LJ, Zerouga M, Stillwell W. Omega-3 fatty acid containing liposomes in cancer therapy. Proc Soc Exp Biol Med 1995, 210: 227-233 [PubMed].
  88. Kafrawy O, Zerouga M, Stillwell W, Jenski LJ. Docosahexaenoic acid in phosphatidylcholine mediates cytotoxicity more effectively then other omega-3 and omega-6 fatty acids. Cancer Lett 1998, 132: 23-29 [CrossRef] [PubMed].
  89. Jenski LJ, Bowker GM, Johnson MA, Ehringer WD, Fetterhoff T, Stillwell W. Docosahexaenoic acid-induced alteration of THY-1 and CD8 expression on murine splenocytes. Biochim Biophys Acta 1995, 1236: 39-50 [PubMed].
  90. Stillwell W, Wassall SR, Dumaual AC, Ehringer WD, Browning CW, Jenski LJ. Use of merocyanine (MC540) in quantifying lipid domains and packing in phospholipid vesicles and tumor cells. Biochim Biophys Acta 1993, 1146: 136-144 [PubMed].
  91. Zerouga M, Jenski LJ, Booster S, Stillwell W. Can docosahexaenoic acid inhibit metastasis by decreasing deformability of the tumor cell plasma membrane? Cancer Lett 1997, 119: 163-168 [CrossRef] [PubMed].
  92. Ellens H, Siegel DP, Alford D, Yeagle PL, Boni L, Lis LJ, Quinn PJ, Bentz J. Membrane fusion and inverted phase. Biochemistry 1989, 28: 3692-3703 [CrossRef] [PubMed].
  93. Williams EE, Jenski LJ, Stillwell W. Docosahexaenoic acid (DHA) alters the structure and composition of membranous vesicles exfoliated from the surface of a murine leukemia cell line. Biochim. Biophys. Acta 1998, 1371: 351-362 [PubMed].
  94. Armstrong VT, Brzustowicz MR, Wassall SR, Jenski LJ, Stillwell W. Rapid flip-flop in polyunsaturated (docosahexaenoate) phospholipid membranes. Arch Biochem Biophys 2003, 414: 74-82 [CrossRef] [PubMed].
  95. Edidin M. Patches and fences: probing for plasma membrane domains. J Cell Sci 1993, Suppl 17: 165-169.
  96. Edidin M. Shrinknig patches and slippery rafts: scales of domains in the plasma membrane. Trends Cell Biol 2001, 11: 493-496.
  97. Edidin M. The state of lipid rafts: from model membranes to cells. Annu Rev Biophys Biomol Struct 2003, 32: 257-283 [CrossRef] [PubMed].
  98. Singer SJ, Nicolson GL. The fluid mosaic model of the structure of cell membranes. Science 1971, 175: 720-731.
  99. Simons K, Ikonnen E. Functional rafts in cell membranes. Nature 1997, 389: 569-572.
  100. Brown DA, London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 2000, 275: 17221-17224 [CrossRef] [PubMed].
  101. Finegold L (Ed). Cholesterol in Membrane Models. CRC Press, Boca Raton, FL, 1993.
  102. Shinitzky M. Membrane fluidity and cellular function. In: Shinitzky M (Ed), Physiology of Membrane Fluidity, CRC Press, Boca Raton, FL, 1984, p 1-51.
  103. Evans RW, Tinoco J. Monolayers of sterols and phosphatidylcholines containing a 20-carbon chain. Chem Phys Lipids 1978, 22: 207-220 [CrossRef] [PubMed].
  104. Zerouga M, Jenski LJ, Stillwell W. Comparison of phosphatidylcholines containing one or two docosahexaenoic acyl chains on properties of phospholipid monolayers and bilayers. Biochim Biophys Acta 1995, 1236: 266-272 [PubMed].
  105. Niu SL, Litman BJ. Determination of membrane cholesterol partition coefficient using a lipid vesicle-cyclodextrin binary system: effect of phospholipid acyl chain unsaturation and head group composition. Biophys J 2002, 83: 3406-3415.
  106. Ghosh D, Williams MA, Tinoco J. The influence of lecithin structure on their monolayer behavior and interactions with cholesterol. Biochim Biophys Acta 1973, 291: 351-362 [PubMed].
  107. Stillwell W, Dallman T, Dumaual AC, Crump FT, Jenski LJ. Cholesterol vs. $\alpha$-tocopherol: effect on properties of bilayers made from heteroacid phosphatidylcholines. Biochemistry 1996, 35: 13353-13362 [CrossRef] [PubMed].
  108. Kariel N, Davidson E, Keough KMW. Cholesterol does not remove the gel-liquid crystalline phase transition of phosphatidylcholines containing two polyenoic acyl chains. Biochim Biophys Acta 1991, 1062: 70-76 [PubMed].
  109. Hernandez-Borrell J, Keough KMW. Heteroacid phosphatidylcholines with different amounts of unsaturation respond differently to cholesterol. Biochim Biophys Acta 1993, 1153: 277-282 [PubMed].
  110. Davis JH. The molecular dynamics, orientational order, and thermodynamic phase equilibria of cholesterol/phosphatidylcholine mixtures: 2H nuclear magnetic resonance. In: Finegold L (Ed), Cholesterol in Model Membranes, Boca Raton, CRC Press, Florida, 1993, p 67-135.
  111. Mitchell DC, Litman BJ. Effect of cholesterol on molecular order and dynamics in highly polyunsaturated phospholipid bilayers. Biophys J 1998, 75: 896-908 [PubMed].
  112. Jackman CS, Davis PJ, Morrow MR, Keough KMW. Effect of cholesterol on the chain-ordering transition of 1-palmitoyl-2-arachidonyl phosphatidylcholine. J Phys Chem B 1999, 103: 8830-8836 [CrossRef].
  113. Brzustowicz MR, Stillwell W, Wassall SR. Molecular organization of cholesterol in polyunsaturated membranes: a solid state 2H NMR investigation. FEBS Lett 1999, 415: 197-202.
  114. Brzustowicz MR, Cherezov V, Zerouga M, Caffrey M, Stillwell W, Wassall SR. Controlling membrane cholesterol content. A role for polyunsaturated (docosahexaenoate) phospholipids. Biochemistry 2000, 41: 12509-12519.
  115. Brzustowicz MR, Cherezov V, Caffrey M, Stillwell W, Wassall SR. Molecular organization of cholesterol in polyunsaturated membranes: microdomain formation. Biophys J 2002, 82: 285-298 [PubMed].
  116. Shaikh SR, Cherezov V, Caffrey M, Stillwell W, Wassall SR. Interaction of cholesterol with a docosahexaenoic acid-containing PE: Trigger for microdomain/raft formation? Biochemistry 2003, 42: 12028-12037 [CrossRef] [PubMed].
  117. Shaikh SR, Brzustowicz MR, Gustafson N, Stillwell W, Wassall SR. Monounsaturated PE does not phase separate form the lipid raft molecules sphingomyelin and cholesterol: role for polyunsaturation? Biochemistry 2002, 41: 10593-1060 [CrossRef] [PubMed].
  118. Pitman MC, Suits F, MacKerell AD Jr, Feller SE. Molecular organization of saturated and polyunsaturated fatty acids in a phosphatidylcholine bilayer containing cholesterol. Biochemistry 2004, 43: 15318-15328 [CrossRef] [PubMed].
  119. Van Dijck PW. Negatively charged phospholipids and their position in the cholesterol affinity sequence. Biochim Biophys Acta 1979, 555: 89-101 [PubMed].
  120. Simons K, Vaz WL. Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct 2004, 33: 269-295 [CrossRef] [PubMed].
  121. Mouritsen OG. Self-assembly and organization of lipid-protein membranes. Curr Opin Coll Int Sci 1998, 3: 78-87.
  122. Shaikh SR, Dumaual AC, Jenski LJ, Stillwell W. Lipid phase separation in phospholipid bilayers and monolayers modeling the plasma membrane. Biochim Biophys Acta 2001, 1512: 317-328 [PubMed].
  123. Pasenkiewicz-Gierula M, Subczynski WK, Kusumi A. Influence of phospholipid unsaturation on the cholesterol distribution in membranes. Biochimie 1991, 73: 1311-1316 [CrossRef] [PubMed].
  124. Niebylski CD, Litman BJ. Lateral phase heterogeneiety in dipolyunsaturated and disaturated phospholipid bilayers monitored with novel pyrene-labeled phospholipids. Biophys J 1997, 72: A305.
  125. Shaikh SR, Dumaual AC, Castillo A, LoCascio D, Siddiqui RA, Stillwell W, Wassall SR. Oleic and docosahexaenoic acid differentially phase separate from lipid raft molecules: A comparative NMR, DSC, AFM and detergent extraction study. Biophys J 2004, 87: 1752-1766 [CrossRef] [PubMed].
  126. Jenski LJ, Caldwell L, Jiricko P, Scherer J, Stillwell W. DHA-Facilitated Membrane Protein Clustering and T-Cell Activation. In: Riemersma RA, Armstrong RA, Kelly RW, Wilson R, Essential Fatty Acids and Eicosanoids, AOCS Press, Champaign, IL, 1998, p 191-196.
  127. Polozova A, Litman BJ. Cholesterol recruitment of di-22:6 PC by a G protein coupled receptor into lateral domains. Biophys J 2000, 79: 2632-2643 [PubMed].
  128. Litman BJ, Niu SL, Polozova A, Mitchell DC. The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways: visual transduction. J Molec Neurosci 2001, 16: 237-242; discussion 279-284.
  129. Salem N Jr, Litman B, Kim HY, Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 2001, 36: 945-959 [PubMed].
  130. Fontaine RN, Harris RA, Schroeder F. Aminophospholipid asymmetry in murine synaptosomal plasma membrane. J Neurochem 1980, 34: 269-277 [PubMed].
  131. Kuypers FA, Abraham S, Lubin B, Chiu D. Diet-induced asymmetry of the phosphatidylcholine fatty acyl composition in rat erythrocyte membranes. J Lab Clin Med 1988, 111: 529-536 [PubMed].
  132. Sweet WD, Schroeder F. Polyunsaturated fatty acids alter sterol transbilayer domains in LM fibroblast plasma membrane. FEBS Lett 1988, 229: 188-192 [CrossRef] [PubMed].
  133. Schroeder F, Jefferson JR, Kier AB, Knittel J, Scallen TJ, Wood WG, Hapala I. Membrane cholesterol dynamics: cholesterol domains and kinetic pools. Proc Soc Exp Biol Med 1991, 196: 235-252 [PubMed].
  134. Lange Y, Dolde J, Steck TL. The rate of transmembrane movement of cholesterol in the human erythrocyte. J Biol Chem 1981, 256: 5321-5323 [PubMed].
  135. Schroeder F, Frolov AA, Murphy EJ, Atshaves BP, Jefferson JR, Pu L, Wood WG, Foxworth WB, Kier AB. Proc Soc Exp Biol Med 1996, 213: 150-177.
  136. Van Dijck PMW, De Kruijff BB, Van Deenen LLM, de Gier J, Demel RA. Preference of cholesterol for phosphatidylcholine in mixed phosphatidylcholine-phosphatidylethanolamine bilayers. Biochim Biophys Acta 1976, 455: 576-587 [PubMed].
  137. Leventis R, Silvius JR. Use of cyclodextrins to monitor transbilayer movement and differential lipid affinities of cholesterol. Biophys J 2001, 81: 2257-2267 [PubMed].
  138. Steck TL, Ye J, Lange Y. Probing red cell membrane cholesterol movement with cyclodextrin. Biophys J 2002, 83: 2118-2125 [PubMed].
  139. Muller P, Herrmann A. Rapid trans-bilayer movement of spin-labeled steroids in human erythrocytes and in liposomes. Biophys J 2002, 82: 1418-1428 [PubMed].
  140. Dusserre E, Pulcini T, Bourdillon MC, Ciavatti, M, Berthezene F. Omega-3 fatty acids in smooth muscle cell phospholipids increase membrane cholesterol efflux. Lipids 1995, 30: 35-41 [PubMed].
  141. Slater SJ, Kelly MB, Taddeo FJ, Ho C, Rubin E, Stubbs CD. The modulation of protein kinase C activity by membrane lipid bilayer structure. J Biol Chem 1994, 269: 4866-4871 [PubMed].
  142. Epand RM. Effect of PKC modulators on membrane properties. In: Lester DS and Epand RM (Eds), Protein Kinase C. Current Concepts and Future Perspectives, Ellis Horwood, Chichester, England, 1992, p 135-156.
  143. Mosior M, Golini ES, Epand RM. Chemical specificity and physical properties of the lipid bilayer in the regulation of protein kinase C by anionic phospholipids: evidence for the lack of a specific binding site for phosphatidylserine. Proc Natl Acad Sci USA 1996, 93: 1907-1912 [CrossRef] [PubMed].
  144. Giorgione J, Epand RM, Buda C, Farkas T. Role of phospholipids containing docosahexaenoyl chains in modulating the activity of protein kinase C. Proc Natl Acad Sci USA 1995, 92: 9767-9770 [PubMed].
  145. Poling JS, Karanian JW, Salem N Jr, Vicini S. Time- and voltage-dependent block of delayed rectifier potassium channels by docosahexaenoic acid. Mol Pharmacol 1995, 47: 381-390 [PubMed].
  146. Poling JS, Vicini S, Rogawski MA, Salem N Jr. Docosahexaenoic acid block of neuronal voltage-gated K+ channels: subunit selective antagonism by zinc. Neuropharmacol 1996, 35: 969-982 [CrossRef].
  147. Pepe S, Bogdanov K, Hallaq H, Spurgeon H, Leaf A, Lakatta E. Omega 3 polyunsaturated fatty acid modulates dihydropyridine effects on L-type Ca2+ channels, cytosolic Ca2+, and contraction in adult rat cardiac myocytes. Proc Natl Acad Sci USA 1994, 91: 8832-8836 [PubMed].
  148. Xiao YF, Gomez AM, Morgan JP, Lederer WJ, Leaf A. Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 1997, 94: 4182-4186 [CrossRef] [PubMed].
  149. Hasler CM, Trosko JE, Bennink MR. Incorporation of n-3 fatty acids into WB-F344 cell phospholipids inhibits gap junctional intercellular communication. Lipids 1991, 26: 788-792 [PubMed].
  150. Jenski LJ, Nanda PK, Jiricko P, Stillwell W. Docosahexaenoic-containing phosphatidylcholine affects the binding of monoclonal antibodies to purified Kb reconstituted into liposomes. Biochim Biophys Acta 2000, 1467: 293-306 [PubMed].
  151. Cohen GM, Sun XM, Snowden RT, Dinsdale D, Skilleter DN. Key morphological features of apoptosis occur in the absence of internucleosomal DHA fragmentation. Biochem J 1987, 286: 331-334.
  152. Van den Eijnde SM, Boshart L, Reuteingsperger CPM, DeZeeuw CI, Vermeij-Keers C. Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis, Cell Death Differ 1997, 4: 311-316.
  153. Williamson P, Schlegel RA. Transbilayer phospholipid movement and the clearance of apoptotic cells. Biochem Biophys Acta 2002, 1585: 53-63.
  154. Diep QN, Intengan HD, Schiffrin EL. Endothelin-1 attenuates $\omega$-3 fatty acid-induced apoptosis by inhibition of caspase 3. Hypertension 2000, 35: 287-291 [PubMed].
  155. Shiina T, Terano T, Saito J, Tamura Y, Yoshida S. Eicosapentaenoic acid and docosapentaenoic acid surpress the proliferation of vascular smooth muscle cells. Atherosclerosis 1993, 104: 95-103 [CrossRef] [PubMed].
  156. Calviello G, Palozza P, Piccioni E, Maggioano N, Frattucci A, Fmceschelli P, Bartoli GM. Dietary supplementation with eicosapentaenoic and docosapentaenoic acid inhibits growth of Morris hepatocarcinoms 3924A in rats: effects on proliferation and apoptosis. Int J Cancer 1998, 75: 699-705 [CrossRef] [PubMed].
  157. Minami M, Noguchi M. Effects of low-dose eicosapentsenoic acid and docosapentaenoic acid and vdietary fat on the incidence, growth and cell kinetics of mammory carcinomas in rats. Oncology 1996, 53: 398-505 [PubMed].
  158. Tsai WS, Nagawa H, Kaizaki S, Tsuruo T, Muto T. Inhibitory effects of n-3 polyunsaturated fatty acids on sigmoid cancer transformants. J Gastroenterol 1998, 33: 206-212 [CrossRef] [PubMed].
  159. Hatala MA, Rayburn J, Rose DP. Comparison of linoleic and eicosapentaenoic acid incorporation into human breast cancer cells. Lipids 1994, 29: 831-837 [PubMed].
  160. Siddiqui RA, Jenski LJ, Neff K, Harvey K, Kovacs RJ, Stillwell W. Docosahexaenoic acid induces apoptosis in Jurcat cells by a protein phosphate-mediated pathway. Biochim Biophys Acta 2001, 1499: 265-275 [PubMed].
  161. Siddiqui RA, Jenski LJ, Wiesehan JD, Hunter MV, Kovacs RJ, Stillwell W. Prevention of docosahexaemoic acid-induced cytotoxicity by phosphatidic acid in jurkat leukemic cells: The Role of Protein Phosphatase-1. Biochim Biophys Acta 2001, 1541: 188-200 [PubMed].
  162. Connolly JM, Gilhooly EM, Rose DP. Effects of reduced dietary linoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice. Nutr Cancer 1999, 35: 44-49 [PubMed].
  163. Siddiqui RA, Shaikh SR, Sech LA, Yount HR, Stillwell W, Zaloga GP. Omega-3 fatty acids: health benefits and cellular mechanisms of action. Mini-Rev Med Chem 2004, 4: 859-871 [PubMed].
  164. Wu M, Harvey KA, Ruzmetov N, Welch ZR, Sech L, Jackson K, Stillwell W, Zaloga GP, Siddiqui RA. Omega-3 polyunsaturated fatty acids attenuate cancer growth through activation of a neural sphingomyelinase-mediated pathway. Int J Cancer 2005, 117: 340-348 [CrossRef] [PubMed].
  165. Jayadev S, Liu B, Bielawaka AE, Lee JY, Nazaire F, Pushkareva M, Obeid LM, Hannun YA. Role for ceramide in cell cycle arrest. J Biol Chem 1995, 270: 2047-2052 [CrossRef] [PubMed].
  166. Rose DP, Connolly JM. Antiangiogenicity of docosahexaenoic acid and its role in the suppression of breast cancer cell growth in nude mice. Int J Oncol 1999, 15: 1011-1015 [PubMed].
  167. Akbar M, Kim HY. Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J Neurochem 2002, 82: 655-665 [CrossRef] [PubMed].
  168. Kim HY, Akbar M, Lau A, Edsall L. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3): role of phosphatidylserine in antiapoptotic effect. J Biol Chem 2000, 275: 35215-35223 [CrossRef] [PubMed].
  169. Kishida E, Yano M, Kasahara M, Masuzawa Y. Distinctive inhibitory activity of docosahexaenoic acid against sphingosine-induced apoptosis. Biochim Biophys Acta 1998, 1391: 401-408 [PubMed].
  170. Huang J, Buboltz JT, Feigenson GW. Maximum solubility of cholesterol in phosphatidylcholine and phosphatidylethanolamine bilayers. Biochim Biophys Acta 1999, 1417: 89-100 [PubMed].